lenalidomide has been researched along with sincalide in 2 studies
| Studies (lenalidomide) | Trials (lenalidomide) | Recent Studies (post-2010) (lenalidomide) | Studies (sincalide) | Trials (sincalide) | Recent Studies (post-2010) (sincalide) |
|---|---|---|---|---|---|
| 3,532 | 725 | 2,850 | 4,015 | 72 | 533 |
| Protein | Taxonomy | lenalidomide (IC50) | sincalide (IC50) |
|---|---|---|---|
| Cholecystokinin receptor type A | Rattus norvegicus (Norway rat) | 0.0006 | |
| Cholecystokinin receptor type A | Homo sapiens (human) | 0.0006 | |
| Gastrin/cholecystokinin type B receptor | Homo sapiens (human) | 0.001 | |
| Gastrin/cholecystokinin type B receptor | Mus musculus (house mouse) | 0.0008 | |
| Cholecystokinin receptor type A | Cavia porcellus (domestic guinea pig) | 0.0004 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Hu, S; Li, Z; Yan, H; Yuan, L | 1 |
1 review(s) available for lenalidomide and sincalide
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for lenalidomide and sincalide
| Article | Year |
|---|---|
Design, synthesis and biological evaluation of Lenalidomide derivatives as tumor angiogenesis inhibitor.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Humans; Lenalidomide; Models, Molecular; Molecular Structure; Neovascularization, Pathologic; Sincalide; Structure-Activity Relationship; Thalidomide | 2017 |